We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The software can also shorten scan times, allowing institutions to schedule more patients a day on their existing scanners, the company said. Read More
In a Complete Response Letter (CRL) to United Therapeutics, the FDA declined to approve the company’s Tyvaso DPI (treprostinil) drug-device combination for improving exercise capacity in patients with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Read More
GammaCore is now cleared for most forms of primary headache, including the acute and preventive treatment of migraine in adolescents and adults, as well as the acute and preventive treatment of cluster headache in adults. Read More
The double-blind, randomized, controlled trial, dubbed STAR–D (safe and timely antithrombotic removal — direct oral anticoagulants), will be conducted in the U.S. Read More
The test can “detect low-abundance markers in a blood sample, unlocking the possibility for earlier, more accessible, noninvasive diagnosis of disease, including [Alzheimer’s disease],” the company said. Read More
Delphinus said the system can identify more cancers using the company’s triple acoustic detection technology that analyzes tissue by recording reflection, speed and attenuation of sound waves. Read More